Metin Kurtoglu, Chief Technology Officer at Cartesian Therapeutics, Inc. (RNAC), sold 27,328 shares at $25.83 ($690K) on 2024-12-09, disclosed to the SEC on 2024-12-11.
Open-market sale of $690k RNAC by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.26 | 6,224 | $157K | 22.8% |
| 2 | $25.26 | 6,224 | $157K | 22.8% |
| 3 | $25.83 | 4,539 | $117K | 17.0% |
| 4 | $25.83 | 4,539 | $117K | 17.0% |
| 5 | $24.35 | 2,901 | $71K | 10.2% |
| 6 | $24.35 | 2,901 |
| $71K |
| 10.2% |
| Total | $25.26 avg | 27,328 | $690K | 100% |
| Filing → |
| RNAC | SELL | 2024-11-18 | $2.8M | — | Filing → |